294 related articles for article (PubMed ID: 1302044)
1. Biotransformation of caffeine, paraxanthine, theobromine and theophylline by cDNA-expressed human CYP1A2 and CYP2E1.
Gu L; Gonzalez FJ; Kalow W; Tang BK
Pharmacogenetics; 1992 Apr; 2(2):73-7. PubMed ID: 1302044
[TBL] [Abstract][Full Text] [Related]
2. Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques.
Tassaneeyakul W; Mohamed Z; Birkett DJ; McManus ME; Veronese ME; Tukey RH; Quattrochi LC; Gonzalez FJ; Miners JO
Pharmacogenetics; 1992 Aug; 2(4):173-83. PubMed ID: 1306118
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of caffeine, paraxanthine, theophylline, and theobromine by polycyclic aromatic hydrocarbon-inducible cytochrome(s) P-450 in human liver microsomes.
Campbell ME; Grant DM; Inaba T; Kalow W
Drug Metab Dispos; 1987; 15(2):237-49. PubMed ID: 2882985
[TBL] [Abstract][Full Text] [Related]
4. Interaction between two probes used for phenotyping cytochromes P4501A2 (caffeine) and P4502E1 (chlorzoxazone) in humans.
Berthou F; Goasduff T; Lucas D; Dréano Y; Le Bot MH; Ménez JF
Pharmacogenetics; 1995 Apr; 5(2):72-9. PubMed ID: 7663531
[TBL] [Abstract][Full Text] [Related]
5. Caffeine metabolism by human hepatic cytochromes P450: contributions of 1A2, 2E1 and 3A isoforms.
Tassaneeyakul W; Birkett DJ; McManus ME; Tassaneeyakul W; Veronese ME; Andersson T; Tukey RH; Miners JO
Biochem Pharmacol; 1994 May; 47(10):1767-76. PubMed ID: 8204093
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of theophylline by cDNA-expressed human cytochromes P-450.
Ha HR; Chen J; Freiburghaus AU; Follath F
Br J Clin Pharmacol; 1995 Mar; 39(3):321-6. PubMed ID: 7619675
[TBL] [Abstract][Full Text] [Related]
7. Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.
Eugster HP; Probst M; Würgler FE; Sengstag C
Drug Metab Dispos; 1993; 21(1):43-9. PubMed ID: 8095225
[TBL] [Abstract][Full Text] [Related]
8. Biotransformation of caffeine in human liver microsomes from foetuses, neonates, infants and adults.
Cazeneuve C; Pons G; Rey E; Treluyer JM; Cresteil T; Thiroux G; D'Athis P; Olive G
Br J Clin Pharmacol; 1994 May; 37(5):405-12. PubMed ID: 8054245
[TBL] [Abstract][Full Text] [Related]
9. Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva.
Fuhr U; Rost KL
Pharmacogenetics; 1994 Jun; 4(3):109-16. PubMed ID: 7920690
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlations.
Fuhr U; Rost KL; Engelhardt R; Sachs M; Liermann D; Belloc C; Beaune P; Janezic S; Grant D; Meyer UA; Staib AH
Pharmacogenetics; 1996 Apr; 6(2):159-76. PubMed ID: 9156694
[TBL] [Abstract][Full Text] [Related]
11. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver.
Daniel WA; Syrek M; Ryłko Z; Kot M
Pol J Pharmacol; 2001; 53(6):615-21. PubMed ID: 11985335
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of caffeine by cDNA-expressed human cytochromes P-450.
Ha HR; Chen J; Krahenbuhl S; Follath F
Eur J Clin Pharmacol; 1996; 49(4):309-15. PubMed ID: 8857078
[TBL] [Abstract][Full Text] [Related]
13. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
[TBL] [Abstract][Full Text] [Related]
14. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1.
Ono S; Hatanaka T; Hotta H; Tsutsui M; Satoh T; Gonzalez FJ
Pharmacogenetics; 1995 Jun; 5(3):143-50. PubMed ID: 7550365
[TBL] [Abstract][Full Text] [Related]
15. Effect of toluidines and dinitrotoluenes on caffeine metabolic ratio in rat.
Jodynis-Liebert J; Matuszewska A
Toxicol Lett; 1999 Jan; 104(1-2):159-65. PubMed ID: 10048762
[TBL] [Abstract][Full Text] [Related]
16. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of theophylline, theobromine and paraxanthine in the fetal rat brain following a single oral dose of caffeine.
Wilkinson JM; Pollard I
Brain Res Dev Brain Res; 1993 Oct; 75(2):193-9. PubMed ID: 8261611
[TBL] [Abstract][Full Text] [Related]
18. Disposition of caffeine and its metabolites in man.
Tang-Liu DD; Williams RL; Riegelman S
J Pharmacol Exp Ther; 1983 Jan; 224(1):180-5. PubMed ID: 6848742
[TBL] [Abstract][Full Text] [Related]
19. Differential activities of CYP1A isozymes in hepatic and intestinal microsomes of control and 3-methylcholanthrene-induced rats.
Spatzenegger M; Horsmans Y; Verbeeck RK
Pharmacol Toxicol; 2000 Feb; 86(2):71-7. PubMed ID: 10728918
[TBL] [Abstract][Full Text] [Related]
20. Two distinct pathways for metabolism of theophylline and caffeine are coexpressed in Pseudomonas putida CBB5.
Yu CL; Louie TM; Summers R; Kale Y; Gopishetty S; Subramanian M
J Bacteriol; 2009 Jul; 191(14):4624-32. PubMed ID: 19447909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
